Skip to main content
ECO ANIMAL HEALTH GROUP PLC logo

ECO ANIMAL HEALTH GROUP PLC — Investor Relations & Filings

Ticker · EAH ISIN · GB0032036807 LEI · 2138009XN9DJ3YP7OB55 IL Manufacturing
Open in API
Filings indexed 406 across all filing types
Latest filing 2025-04-24 Earnings Release
Country GB United Kingdom
Listing IL EAH

About ECO ANIMAL HEALTH GROUP PLC

https://www.ecoanimalhealthgroupplc.com/

ECO Animal Health Group is a global company specializing in the development, registration, and marketing of pharmaceutical and biological products for animal health. The company's primary focus is on improving the health, welfare, and productivity of pigs and poultry by addressing economically significant respiratory and enteric diseases. Its key product is Aivlosin®, a macrolide antibiotic also marketed as Valosin®. Through its dedicated research and development, the company creates innovative solutions, including vaccines and other pharmaceuticals, to support sustainable and safe food production. ECO Animal Health operates worldwide, leveraging a global network of distributors and direct market presence.

Recent filings

Filing Released Lang Actions
Trading Update
Earnings Release Classification · 1% confidence The document is a 'Trading Update' issued by ECO Animal Health Group plc via the Regulatory News Service (RNS). It provides preliminary financial highlights (EBITDA and revenue expectations) for the fiscal year ended 31 March 2025, ahead of the full audited Annual Report. Since it is an initial announcement of financial performance metrics rather than the full report itself, and it fits the definition of an Earnings Release (ER) which covers key highlights of financial results, it is classified as an Earnings Release. FY 2025
2025-04-24 English
R&D Day
Regulatory Filings Classification · 1% confidence The document is a formal announcement disseminated via RNS (RNS Number : 4590A) from Eco Animal Health Group plc. The content explicitly states that the company is 'hosting an R&D Day today for institutional and private investors and analysts' and provides details about the event, speakers, and registration. This type of announcement, focusing on an investor event designed to present strategy and pipeline insights, aligns best with the Investor Presentation (IP) category, although it is an announcement *about* the presentation/event rather than the presentation slides themselves. However, since the event is an 'R&D Day' focused on pipeline and value creation, it functions as a major investor communication event. Given the options, it is not a standard Earnings Release (ER), Interim Report (IR), or a formal proxy/governance document. It is an announcement regarding an investor-facing event. If the content were the slides, it would be IP. Since it is the announcement of the event, and it is a specific type of investor communication, it is closest to an Investor Presentation (IP) announcement, or potentially a Regulatory Filing (RNS) if we strictly follow the 'announcement of a report' rule. Since the event itself is an R&D Day, which is a form of investor presentation, I will classify it as IP, as it is more specific than the general RNS fallback, and the document is short enough to be considered an announcement rather than the full presentation material itself. However, looking closely at the definitions, there is no specific code for 'Investor Event Announcement'. It is an announcement about an event where presentations will be given. This is a common type of filing that often falls under RNS or sometimes IP if the content is highly detailed. Given the context of an R&D Day presentation, IP is the most relevant thematic category for the *subject matter*. Since it is an announcement of an event, and not the report itself, RNS is the safest fallback for an announcement that doesn't fit the specific report codes. Let's re-evaluate: It announces an R&D Day where presentations will be given. This is a specific type of investor relations activity. It is not a standard ER, IR, or 10-K. It is not a proxy (DEF 14A/PSI). It is not a dividend (DIV). It is an announcement about an investor event. This is highly specific investor communication. I will classify it as Investor Presentation (IP) because the core purpose is to present R&D pipeline and value creation to investors, which is the function of an IP, even if this specific document is the announcement of the event.
2025-03-13 English
Submission of Marketing Authorisation Application
Regulatory Filings Classification · 1% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the concluding boilerplate text referencing RNS and the London Stock Exchange. The content announces a specific corporate action: the submission of a Marketing Authorisation Application to the EMA for a new vaccine. This type of material, which is a general regulatory announcement about a significant event (submission for approval, not the approval itself), fits best under the 'Regulatory Filings' category, which serves as a general announcement/miscellaneous category when a more specific one (like CAP for financing or LTR for legal action) does not apply. Since it is an announcement of a regulatory step, and not a full report, 'RNS' is the most appropriate code.
2025-03-03 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains structured data fields typical of regulatory filings concerning changes in share ownership thresholds. Specifically, it details an 'acquisition or disposal of voting rights' by 'Killik & Co LLP' and reports the resulting percentage of voting rights (3.065900%). This type of filing, reporting changes in significant shareholdings, maps directly to the Major Shareholding Notification category. The presence of 'RNS Number' and references to the London Stock Exchange confirm its regulatory nature, but the specific content points to MRQ over the general RNS fallback.
2025-02-24 English
Disposal of non-core assets
M&A Activity Classification · 1% confidence The document is a formal announcement released via RNS (Regulatory News Service) on February 19, 2025. It details a specific corporate action: the 'Disposal of non-core product lines' for a total consideration of £491,000. This type of announcement, which concerns a significant transaction (asset disposal) and provides commentary from management, is typically classified as a general regulatory announcement or a specific transaction announcement. Since there is no specific code for 'Asset Disposal' and it is not a standard financial report (10-K, IR, ER), nor a management discussion (MDA), nor a capital change (CAP/SHA), it fits best under the general regulatory filing category, RNS, as it is a material event disclosed through the official news service.
2025-02-19 English
Block listing Interim Review
Remuneration Information Classification · 1% confidence The document is explicitly labeled with "RNS Number : 4219X" and contains boilerplate text referencing RNS, the news service of the London Stock Exchange, and the Financial Conduct Authority (FCA). The content itself is a "BLOCK LISTING RETURN" detailing the balance of unallotted securities under share option schemes over a specific period (August 9, 2024, to February 9, 2025). This type of filing, which reports on the status of listed securities or specific corporate actions via the RNS system, fits best under the general regulatory announcement category, as there is no specific code for a 'Block Listing Return'. Given the source (RNS) and the nature of the update (a routine regulatory disclosure not covered by more specific codes like DIV, SHA, or POS), the most appropriate classification is Regulatory Filings (RNS). The document length is short (3490 chars), but it is the primary filing itself, not an announcement *about* a filing.
2025-02-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.